Granules India surges 6% on Carlyle group acquisition buzz
Carlyle is expected to buy 42 per cent of promoter shares, which will trigger an open offer to acquire additional stake from others, CNBC TV18 report.01-12-2020
01-12-2020
Granules India (418.6): Buy
The stock of Granules India, which was moving in a sideways trend, broke out of the range on Tuesday, opening the door for further appreciation. Hence24-11-2020
GRANULES INDIA LTD.-$ - 532482 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate18-11-2020
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting09-11-2020
Granules India board gives nod to set up subsidiary in Hyderabad
Company to build greenfield unit for formulations biz09-11-2020
GRANULES INDIA LTD.-$ - 532482 - Outcome Of Board Meeting Dated 9Th November 2020
Outcome of Board Meeting dated 9th November 202009-11-2020
Buy Granules India; target of Rs 460: ICICI Direct
ICICI Direct is bullish on Granules India recommended buy rating on the stock with a target price of Rs 460 in its research report dated October 21, 2020.03-11-2020
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting02-11-2020
GRANULES INDIA LTD.-$ - 532482 - Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliance under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201502-11-2020
Two more drug firms to set shop in Genome Valley
Our Bureau Drug-makers Granules India Ltd and Laurus Labs have announced independent plans to set up new manufacturing facilities in Genome Valley, H27-10-2020